Ledger.Open graph →
SEC Form D · Amendment · filed March 27, 2026

Nexo Therapeutics, Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LITTLETON, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Walter Raquet · Warba, MNDirectorManish Thakur · New York, NYExec · DirectorRichard A. Smith, Jr · Manhattan Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗